ATR and ovarian carcinoma: Since the addition of ATR inhibition to CHK1 inhibition is known to induce DNA replication catastrophe in cancer cells (65), we decided to further evaluate the impact of ATRi-CHK1i in the ovarian cancer cells, specifically at low doses.